Condition
Sleep Apnea/Hypopnea Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Unknown1
Terminated1
Enrolling By Invitation1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07399782Phase 2Not Yet Recruiting
Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea
NCT06915077Enrolling By Invitation
Personalised Treatment for OSA
NCT02569749TerminatedPrimary
Sleep Apnea Screening
NCT02143297UnknownPrimary
Automatic Estimation of the Apnea-hypopnea Index Using Neural Networks to Detect Sleep Apnea
Showing all 4 trials